T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges
Summary: T cell-engaging bispecific antibodies (T-BsAbs) have revolutionized immunotherapy for hematologic malignancies, showing promise in lymphoid cancers and myeloma. However, their application in myeloid malignancies like acute myeloid leukemia (AML) faces challenges due to myelotoxicity and lim...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Elsevier
2026-05-01
|
| মালা: | Cell Reports Medicine |
| অনলাইন ব্যবহার করুন: | http://www.sciencedirect.com/science/article/pii/S2666379126001898 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|